Non seulement Nathan Peiffer-Smadja est Coordinateur du RéJIF, un groupe de travail de la SPILF mais aussi membre de l’Imperial College London où officie Nigel Ferguson le roi du confinement. Pour rappel les généreux donateurs de la SPILF, qui ne sont autres que les usual suspects de Big Pharma ...
Je regarde votre premier lien, aucun rapport avec l’HCQ ??!!
Table 4
shows the management given to hospitalized patients. Almost all
patients were given LMWH and antibiotics, with all males receiving the
latter (p=0.02). Majority (∼97%) also received vitamin C, vitamin D and
azithromycin. Majority also received hydroxychloroquine (89%) and
dexamethasone (68.7%).
Table 5 ... ... Among the treatment options, patients who were given
methylpredinosolone, dexamethasone, hydroxychloroquine and azithromycin
were significantly less likely to die from Covid-19 by as much as 65%,
80%, 88% and 97%, respectively.
3. Discussion ....
Worthy to mention are the protective effects of corticosteroids
(dexamethasone and methylprednisolone) as well as hydroxychloroquine
from severe Covid-19 outcomes. Hydroxychloroquine in particular protects
from Covid-19 death by 88% in the dataset studied. This percentage,
while much higher compared to other recent studies done elsewhere [16], [17], [18],
reiterates that the use of hydroxychloroquine is associated with
reduced Covid-19 mortality. Several studies however do not consider the
use of hydroxychloroquine beneficial for Covid-19 treatment [19], [20].
These differences can be partly explained by differences in research
methods, some of which were flawed and biased given the premature media
attention it received prior to approval [21]. The use of hydroxychloroquine however in Saudi Arabia is approved by the Ministry of Health. ....
Donc si il y en a un qui se fout de la gueule de l’autre c’est bien vous. Vous êtes pénible ... Avant d’écrire apprenez à lire sinon je vais croire que vous testez la dernière molécule megatroll de Big Pharma ...
@pemile Du tout, les médecins qui ont utilisé l’HCQ lors de la première vague ont laissé tomber.
Si vous aviez consulté mon lien (https://c19study.com/), vous auriez lu que l’étude Boulware est citée 4 fois (6/3, 7/18, 9/27, 9/28). Depuis le début du mois de novembre, 14 études ont été publiées émanant de pays aussi divers que les USA, Brésil, Espagne, Inde, Bulgarie, Arabie Saoudite ... Preuve que des médecins continuent à utiliser l’HCQ.